ARCHIVES

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

Professional Societies: ASCO Foundation Formed to Support Fellowship Awards

June 11, 1999

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

Cervical Cancer Screening Can Be Done Later, Less Often

December 25, 2009

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Entire Construction Budget In 1983 Goes to Two Grants; Help May Be On The Way

February 25, 1983

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

February 24, 2012